News: IV immunoglobulin for Alzheimer disease: No ARIA, no win?
Latest released contribution from Dr. Piazza Fabrizio on Neurology @GreenJournal What is the accepted risk between optimizing positive effects and reducing ARIA…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
- Uncategorized
Post: Disponibilità Immediata per Tesi Sperimentale in Biotecnologie/Biologia/Farmacologia: CHARACTERIZATION OF MONOMERIC-OLIGOMERIC- AND FIBRILLAR-ANTI-Aβ AUTOANTIBODIES IN CEREBRAL AMILOYD ANGIOPHATY-RELATED INFLAMMATION AND ALZHEIMER’S DISEASE PATIENTS
E’ disponibile una posizione per lo svolgimento di una Tesi Sperimentale (disponibilità immediata) presso il gruppo coordinato dal Dott. Piazza Fabrizio….
News: Disponibilità per Tesi Sperimentale in Biotecnologie/Biologia/Farmacologia: CHARACTERIZATION OF MONOMERIC-OLIGOMERIC- AND FIBRILLAR-ANTI-Aβ AUTOANTIBODIES IN CEREBRAL AMILOYD ANGIOPHATY-RELATED INFLAMMATION AND ALZHEIMER’S DISEASE PATIENTS
E’ disponibile una posizione per lo svolgimento di una Tesi Sperimentale (disponibilità immediata) presso il gruppo coordinato dal Dott. Piazza Fabrizio….
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
- Computational and Systems Neuroscience
Event: New congress at NeuroMI: Prediction and prevention of dementia – A new hope
A new hope is arising to defeat Alzheimer Disease, the major cause of dementia, now affecting 25 million worldwide and predicted…
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
- Cognitive and Behavioural Neuroscience
News: HERE WE ARE!! The 50 most influential Alzheimer’s Disease research papers of the last five years.
Our Annals of Neurology 2013 manuscript has been included between the 50 most influential Alzheimer’s Disease research papers of the last…
News: Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers?
I’m glad to share with you all this manuscript I Co-Authored with Bengt Winblad. At the 8th International Conference on…
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
- Clinical Neuroscience
Journal club entry: Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.
I’m glad to share with you the latest manuscript published in collaboration with our Network Collaborators in Barcelona. link: https://sites.google.com/site/icabinternationalnetwork/publications Cerebrospinal…
News: 8TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD 2015), Barcelona, Spain
Thursday, November 5th at 4.45pm, Dr. Piazza Fabrizio will present the latest iCAβ International Network Research News at the 8TH CLINICAL TRIALS ON ALZHEIMER’S…
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
- Molecular and Cellular Neuroscience
Journal club entry: Prodromal Alzheimer’s disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.
J Alzheimers Dis. 2015;45(2):363-7. doi: 10.3233/JAD-142376 Prodromal Alzheimer’s disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and…
Journal club entry: Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management. (NeuroMI paper)
Case Rep Neurol Med. 2015;2015:483020. doi: 10.1155/2015/483020. Epub 2015 Aug 16. Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult…
News: Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.
Here is the just released Frontiers of Neurology Review. In the manuscript, we gave an update of all the results of…
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
- Neuroimaging and Methodological research
Journal club entry: Clinical and neuroradiological evolution of CAA-ri recurrence in the longitudinal cohort of cases from the iCAβ International Network. (NeuroMI paper)
Here is the last JAD manuscript where we described the evolution of the clinical and neuroradiological features of Cerebral Amyloid Angiopathy-related…